Search for: "May v. Amgen, Inc."
Results 41 - 60
of 298
Sorted by Relevance
|
Sort by Date
6 Apr 2011, 2:37 am
It is also the name of a drug produced by Swedish Orphan Biovityrum AB allegedly under license from Amgen Inc. [read post]
9 Jan 2021, 9:16 am
Connolly, in Amgen Inc. et al. v. [read post]
7 Mar 2013, 7:17 am
In Amgen Inc. v. [read post]
22 May 2023, 4:59 pm
On May 18, 2023, the Supreme Court of the United States issued a unanimous decision in the case of Amgen Inc. et al. v. [read post]
27 May 2009, 9:55 pm
Amgen Inc. 2:09-cv-02256; filed May 20, 2009 in the Eastern District of Pennsylvania Infringement of U.S. [read post]
21 Jun 2016, 1:38 pm
Amgen Inc., et al., No. 15-1039 (petition for writ of ceritorari filed February 16, 2016; 4 briefs filed in support); and Amgen Inc., et al. v. [read post]
21 Apr 2023, 9:27 am
By Chris Holman Amgen Inc. v. [read post]
27 Mar 2007, 3:29 pm
Amgen Inc. has recently filed this new cert. petition in the case of Amgen v. [read post]
12 Jun 2012, 10:43 am
On Monday, June 11, 2012, the Supreme Court granted a Writ of Certiorari in Amgen, Inc. v. [read post]
15 May 2007, 6:59 am
See Amgen Inc. v. [read post]
7 Mar 2013, 9:45 am
In Amgen Inc. v. [read post]
21 Jun 2013, 11:26 am
John Fund, Inc. v. [read post]
27 Jan 2016, 6:52 am
Dudenhoeffer (Amgen Inc. v. [read post]
6 Oct 2017, 2:34 pm
CAFC holds that later-developed antibody species may be evidence that a claimed antibody genus is invalid for lack of written description, and casts doubt on the “antibody exception” Amgen Inc. v. [read post]
6 Oct 2017, 2:34 pm
CAFC holds that later-developed antibody species may be evidence that a claimed antibody genus is invalid for lack of written description, and casts doubt on the “antibody exception” Amgen Inc. v. [read post]
16 May 2022, 12:16 pm
Qualcomm Incorporated (licensee appellate standing) and Amgen Inc. v. [read post]
23 Mar 2023, 11:41 am
In Amgen Inc. v. [read post]
8 Nov 2016, 8:23 pm
The petition of the day is: Apotex Inc. v. [read post]
27 Apr 2023, 11:51 am
The pending Supreme Court case of Amgen Inc. v. [read post]
8 May 2021, 10:26 pm
The panel will cover recent developments in the Hatch-Waxman and BPCIA litigation and legislation, in particular, the Federal Circuit decisions in Amgen Inc. v. [read post]
